Intracellular metabolism of 3′-azido-3′-deoxythymidine in the presence of ganciclovir or foscarnet

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 1, 1996, Pages 14-20

  Palmer, S ^a,b   Rasmussen, H ^a   Harmenberg, J ^c   Cox, S ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Astra Arcus AB   (Sweden)

Author keywords

Antiviral; Azidothymidine; AZT TP; CMV; Foscarnet; Ganciclovir; Phosphorylation

Indexed keywords

DEOXYNUCLEOSIDE TRIPHOSPHATE; FOSCARNET; GANCICLOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE; ZIDOVUDINE DIPHOSPHATE; ZIDOVUDINE TRIPHOSPHATE;

ARTICLE; CELL LEVEL; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; LYMPHOBLASTOID CELL LINE; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0030054056     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700103     Document Type: Article

References (49)

1. Aweeka, F., Gambertoglio, J., Mills, J., and Jacobson, M.A. (1989) Pharmacokinetics of intermittently administered intravenous foscamet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob Agents Chemother 33: 742-745.
2. Betts, R.F. (1982) Cytomegalovirus infection in transplant patients. Prog Med Virol 28: 44-64.
3. Collaborative DHPG Treatment Study Group (1986) Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. N Eng J Med 314: 801-805.
4. Cox, S., Vissgården, A., and Wahren, B. (1993) Effect upon the anti-HIV activity of 3′-azido-3′-deoxythymidine and 3′-fluoro-3′-deoxythymidine of combination with anti-herpes nucleoside analogues. Antiviral Chem Chemother 4: 41-47.
5. Davis, M.G., Kenney, S.C., Kamine, J., Pagano, J.S., and Huang, E.-S. (1987) Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci USA 84: 8642-8646.
6. Eriksson, B.F.H., and Schinazi, R.F. (1989) Combinations of 3′-azido-3′-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Antimicrob Agents Chemother 33: 663-669.
7. Estes, J.E., and Huang, E.-S. (1977) Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol 24: 13-21.
8. Fletcher, C.V., Collier, A.C., Rhame, F.S., Bennett, D., Para, M.F., Beatty, C.C , Jones, C.E., and Balfour Jr., H.H. (1994) Foscamet for suppression of human immunodeficiency virus replication. Antimicrob Agents Chemother 38: 604-607.
9. Freitas, V.R., Smee, D.F., Chernow, M., Boehme, R., and Matthews, T.R. (1985) Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses. Antimicrob Agents Chemother 28: 240-245.
10. Furman, P.A., Fyfe, J.A., St. Clair, M.H., Weinhold, K., Rideout, J.L., Freeman, G.A., Lehrman, S.N., Bolognesi, D.P., Broder, S., Mitsuya, H., and Barry, D.W. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337.
11. Gallant, J.E., Moore, R.D., Richman, D.D., Keruly, J., Chaisson, R.E., and the Zidovudine Epidemiology Study Group (1992) Incidence and natural history of cytomegalovirus _disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166: 1223-1227.
12. Gao, W.-Y., Shirasaka, T., Johns, D.G., Broder, S., and Mitsuya, H. (1993) Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 91: 2326-2333.
13. Guarda, L.A., Luna, M.A., Smith Jr., J.L., Mansell, P.W.A., Gyorkey, F., and Roca, A.N. (1984) Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol 81: 549-557.
14. Harmenberg, J., Cox, S., and Åkesson-Johansson, A. (1990) Improved sample preparation method for high-performance liquid chromatography of deoxyribonucleoside triphosphates from cell culture extracts. J Chromatogr 508: 75-79.
15. Harris, M.L., and Mathalone, M.B.R. (1987) Dihydroxypropoxymethyl guanine in the treatment of AIDS related retinitis due to cytomegalovirus. BMJ 294: 92.
16. Helgstrand, E., Eriksson, B., and Johansson, N.G. (1978) Trisodium phosphonoformate, a new antiviral compound. Science 201: 819-821.
17. Ho, W.-Z., Song, L., and Douglas, S.D. (1991) Human cytomegalovirus infection and trans-activation of HIV-1 LTR in human brain-derived cells. J Acquir Immune Defic Syndr 4: 1098-1106.
18. Hochster, H., Dieterich, D., Bozzette, S., Reichman, R., Connor, J.D., Liebes, L., Sonke, R.L., Spector, S.A., Valentine, F., Pettinelli, C., and Richman, D.D. (1990) Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. Ann Intern Med 113: 111-117.
19. Jacobson, M.A., Causey, D., Polsky, B., Hardy, D., Chown, M., Davis, R., O'Donnell, J.J., Kupperman, B.D., Heinemann, M.-H., Holland, G.N., Mills, J., and Feinberg, J.E. (1993) A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis 168: 444-448.
20. Jacobson, M A., De Miranda, P., Gordon, S.M., Blum, M.R., Volberding, P., and Mills, J. (1988b) Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy. J Infect Dis 158: 489-490.
21. Jacobson, M.A., Drew, W.L., Feinberg, J., O'Donnell, J.J., Whitmore, P.V., Miner, R.D., and Parenti, D. (1991) Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis 163: 1348-1351.
22. Jacobson, M.A., Kramer, F., Bassiakos, Y., Hooton, T., Polsky, B., Geheb, H., O'Donnell, J.J., Walker, J.D , Korvick, J.A., and van der Horst, C. (1994b) Randomized phase I trial of two different combination foscamet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical trials group protocol 151. J Infect Dis 170: 189-193.
23. Jacobson, M.A., and Mills, J. (1988a) Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108: 585-594.
24. Jacobson, M.A., Wulfsohn, M., Feinberg, J.E., Davis, R., Power, M., Owens, S., Causey, D., Heath-Chiozzi, M.E., Murphy, R.L., Cheung, T.W., Dieterich, D.T., Spector, S.A., McKinley, G.F., Parenti, D.M., Crumpacker, C., and the AIDS clinical trials group of the National Institute of Allergy and Infectious Diseases, (1994a) Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS 8: 451-459.
25. Jault, F.M., Spector, S.A., and Spector, D.H. (1994) The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol 68: 959-973.
26. Khym, J. (1975) An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem 21: 1245-1252.
27. Kong, X.-B., Zhu, Q.-Y., Ruprecht, R., Watanabe, K., Zeidler, J., Gold, J., Polsky, B., Armstrong, D., and Chou, T.-C. (1991) Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two drug and three drug combinations of 3′-azido-3′-deoxythymidine, phosphonoformate, and 2′,3′-dideoxythymidine. Antimicrob Agents Chemother 35: 2003-2011.
28. Koshida, R., Cox, S., Harmenberg, J., Gilljam, G., and Wahren, B. (1989) Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob Agents Chemother 33: 2083-2088.
29. Koval, V., Clark, C., Vaishnav, M., Spector, S.A., and Spector, D.H. (1991) Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol 65: 6969-6978.
30. Laskin, O.L , Stahl-Bayliss, C.M., Kalman, C.M., and Rosecan, L.R. (1987) Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J Infect Dis 155: 323-327.
31. Littler, E., Stuart, A., and Chee, M. (1992) Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358: 160-162.
32. Masur, H., Lane, H.C., Palestine, A., Smith, P.D., Manischewitz, J., Stevens, G., Fujikawa, L., Macher, A.M., Nussenblatt, R., Baird, B., Megill, M., Wittek, A., Quinnan, G.V., Parrillo, J.E., Rook, A.H., Eron, L.J., Poretz, D.M., Goldenberg, R.I., Fauci, A.S , and Gelmann, E.P. (1986) Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Intern Med 104: 41-44.
33. Medina, D.J., Hsiung, G.D., and Mellors, J.W. (1992) Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro. Antimicrob Agents Chemother 36: 1127-1130.
34. Millar, A.B., Miller, R.F., Patou, G., Mindel, A., Marsh, R., and Sample, S.J G. (1990) Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: out-come and toxicity. Genitourin Med 66: 156-158.
35. Moskowitz, L., Hensley, G.T., Chan, J.C., and Adams, K. (1985) Immediate causes of death in acquired immunodeficiency syndrome. Arch Pathol Lab Med 109: 735-738.
36. Öberg, B. (1983) Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther 19: 387-415.
37. Palestine, A.G., Polis, M.A., De Smet, M.D., Baird, B.F., Falloon, J., Kovacs, J.A., Davey, R.T., Zurlo, J.J., Zunich, K.M., Davis, M., Hubbard, L., Brothers, R., Ferris, F.L., Chew, E., Davis, J.L., Rubin, B.I., Mellow, S.D., Metcalf, J.A., Manischewitz, J., Minor, J.R., Nussenblatt, R.B., Masur, H., and Lane, H.C. (1991) A randomized, controlled trial of foscamet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 115: 665-673.
38. Palmer, S., and Cox, S. (1994a) Comparison of extraction procedures for high-performance liquid chromatography analysis of cellular deoxynucleotides. J Chromatogr A 667: 316-321.
39. Palmer, S., and Cox, S. (1994b) Intracellular metabolism of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine in combination in the absence and presence of ribavirin. Antiviral Chem Chemother 5: 403-409.
40. Palmer, S., and Cox, S. (1995) Intracellular activation and cytotoxicity of three different combinations of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine. AIDS Res Hum Retroviruses 11 (10): 1227-1233.
41. Pertel, P., Hirschtick, R., Phair, J., Chmiel, J., Poggensee, L., and Murphy, R. (1992) Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acq Immune Defic Syndr 5: 1069-1074.
42. Prichard, M., Prichard, L., Baguley, W., Nassiri, M., and Shipman, C. (1991) Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob Agents Chemother 35: 1060-1065.
43. Schooley, R.T. (1990) Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev Infect Dis 12: S811-S819.
44. Studies of ocular complications of AIDS research group, in collaboration with the AIDS clinical trials group (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326: 213-220.
45. Sullivan, V., Talanco, C., Stanat, S., Davis, M., Coen, D., and Biron, K. (1992) A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358: 162-164.
46. Tanaka, K., Yoshioka, A., Tanaka, S., and Wataya, Y. (1984) An Improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 139: 35-41.
47. Tömevik, Y., Jacobsson, B., Britton, S., and Eriksson, S. (1991) Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 7: 751-759.
48. Wachsman, M., Hamzeh, F.M., Saito, H., and Lietman, P.S. (1995) Specific anti-cytomegaloviral activity of methotrexate associated with preferential accumulation of drug by infected cells. Antiviral Res 26: A321.
49. Wagstaff, A.J., and Bryson, H.M. (1994) Foscarnet. Drugs 48: 199-226.